1. Han, Lisa, Liu, Yajuan J, Ricciotti, Robert W, Mantilla, Jose G. 2020. A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review. In Genes, chromosomes & cancer, 59, 428-432. doi:10.1002/gcc.22845. https://pubmed.ncbi.nlm.nih.gov/32237188/
2. Hofvander, Jakob, Jo, Vickie Y, Fletcher, Christopher D M, Magnusson, Linda, Mertens, Fredrik. 2020. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 33, 1331-1340. doi:10.1038/s41379-020-0457-8. https://pubmed.ncbi.nlm.nih.gov/31932680/
3. Srivastava, Pooja, Zilla, Megan L, Naous, Rana, Surrey, Lea F, John, Ivy. 2023. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2. In Histopathology, 82, 946-952. doi:10.1111/his.14868. https://pubmed.ncbi.nlm.nih.gov/36648026/
4. Micci, Francesca, Gorunova, Ludmila, Gatius, Sonia, Heim, Sverre, Panagopoulos, Ioannis. 2014. MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma. In Cancer letters, 347, 75-8. doi:10.1016/j.canlet.2014.01.030. https://pubmed.ncbi.nlm.nih.gov/24530230/
5. Yang, Yang, Wang, Chenji, Zhang, Pingzhao, Huang, Haojie, Yu, Long. 2012. Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis. In The Journal of biological chemistry, 288, 529-39. doi:10.1074/jbc.M111.338996. https://pubmed.ncbi.nlm.nih.gov/23150668/
智鼠故事 
